Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Secondary Amine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel metal-free catalyst technology enabling high-purity chiral secondary amines with significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel one-pot method reduces alcohol by-products. Enhances supply chain reliability for high-purity secondary diamine manufacturing with significant cost advantages.
Patent CN108358793B details a green one-pot synthesis of secondary amines from alkynes, offering significant cost reduction in API manufacturing without metal catalysts.
Novel Cu/Nb2O5 catalyst enables efficient secondary amine production. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN116924916B details a novel catalyst-free reductive amination method offering high selectivity and supply chain stability for pharmaceutical intermediates manufacturing.
Patent CN113583992A reveals a novel RsRedAm enzyme for efficient secondary amine synthesis, offering mild conditions and high selectivity for pharmaceutical intermediates.
Novel Pd/C catalytic method ensures high purity and yield. Reduces steps for pharmaceutical intermediate manufacturing. Reliable supply chain partner.
Patent CN110818576B reveals a novel rare earth catalyzed synthesis of secondary amines. High yield, mild conditions, and cost-effective supply chain solutions for pharma.
Patent CN103864624A reveals a solvent-free, metal-free N-alkylation method. Discover cost-effective manufacturing and high-purity supply chain solutions for pharmaceutical intermediates.
Patent CN110862324A discloses a novel iridium-catalyzed asymmetric reductive amination method achieving up to 95% ee for key pharmaceutical intermediates like Cinacalcet.
Novel one-step iridium-catalyzed method for fluorine-containing secondary amines using stable fluorinated alcohols, offering significant cost and safety advantages for pharmaceutical manufacturing.
Novel boron-catalyzed hydroamination method offers high yield and mild conditions for pharmaceutical intermediates manufacturing ensuring supply chain reliability.
Patent CN116283937B reveals metal-free photocatalytic synthesis for high-purity aromatic secondary amines, offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Patent CN107382741B details a high-yield B(C6F5)3 catalyzed hydroamination. Offers cost-effective, scalable routes for pharmaceutical intermediates with minimal impurities.
Discover a novel, catalyst-free synthesis of N-nitrosamines using sulfonyl fluoride. Enhance purity and reduce costs in pharmaceutical intermediate manufacturing with this green technology.